Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 481

1.

Expression of insulin-like growth factor-1 receptor in metastatic uveal melanoma and implications for potential autocrine and paracrine tumor cell growth.

Yoshida M, Selvan S, McCue PA, DeAngelis T, Baserga R, Fujii A, Rui H, Mastrangelo MJ, Sato T.

Pigment Cell Melanoma Res. 2014 Mar;27(2):297-308. doi: 10.1111/pcmr.12206. Epub 2014 Jan 6.

PMID:
24354797
2.

Nutrient restriction and radiation therapy for cancer treatment: when less is more.

Champ CE, Baserga R, Mishra MV, Jin L, Sotgia F, Lisanti MP, Pestell RG, Dicker AP, Simone NL.

Oncologist. 2013;18(1):97-103. doi: 10.1634/theoncologist.2012-0164. Epub 2013 Jan 8. Review.

3.

Growth of v-src-transformed cells in serum-free medium through the induction of growth factors.

Deangelis T, Quong A, Morrione A, Baserga R.

J Cell Physiol. 2013 Jul;228(7):1482-6. doi: 10.1002/jcp.24303.

4.

The decline and fall of the IGF-I receptor.

Baserga R.

J Cell Physiol. 2013 Apr;228(4):675-9. doi: 10.1002/jcp.24217. Review.

PMID:
22926508
5.

Inhibition of the single downstream target BAG1 activates the latent apoptotic potential of MYC.

Zhang XY, Pfeiffer HK, Mellert HS, Stanek TJ, Sussman RT, Kumari A, Yu D, Rigoutsos I, Thomas-Tikhonenko A, Seidel HE, Chodosh LA, Packham G, Baserga R, McMahon SB.

Mol Cell Biol. 2011 Dec;31(24):5037-45. doi: 10.1128/MCB.06297-11. Epub 2011 Oct 10.

6.

The type 1 insulin-like growth factor receptor and resistance to DACH1.

DeAngelis T, Wu K, Pestell R, Baserga R.

Cell Cycle. 2011 Jun 15;10(12):1956-9. Epub 2011 Jun 15.

PMID:
21558809
7.

Self-plagiarism in music and science.

Baserga R.

Nature. 2011 Feb 3;470(7332):39. doi: 10.1038/470039e. No abstract available.

PMID:
21293358
8.

Regulation of microRNA-145 by growth arrest and differentiation.

La Rocca G, Shi B, Audia A, Ferrari-Amorotti G, Mellert HS, Calabretta B, McMahon SB, Sepp-Lorenzino L, Baserga R.

Exp Cell Res. 2011 Feb 15;317(4):488-95. doi: 10.1016/j.yexcr.2010.11.010. Epub 2010 Nov 25.

PMID:
21111732
9.

Expression of micro-RNA-145 is regulated by a highly conserved genomic sequence 3' to the pre-miR.

La Rocca G, Shi B, Sepp-Lorenzino L, Baserga R.

J Cell Physiol. 2011 Mar;226(3):602-7. doi: 10.1002/jcp.22368.

PMID:
20717966
10.

Mutual interaction and reciprocal down-regulation between c-met and insulin receptor substrate-1.

DeAngelis T, Morrione A, Baserga R.

J Cell Physiol. 2010 Sep;224(3):658-63. doi: 10.1002/jcp.22164.

PMID:
20578241
11.

microRNA, cell cycle, and human breast cancer.

Yu Z, Baserga R, Chen L, Wang C, Lisanti MP, Pestell RG.

Am J Pathol. 2010 Mar;176(3):1058-64. doi: 10.2353/ajpath.2010.090664. Epub 2010 Jan 14. Review.

12.

The microRNA miR-92 increases proliferation of myeloid cells and by targeting p63 modulates the abundance of its isoforms.

Manni I, Artuso S, Careccia S, Rizzo MG, Baserga R, Piaggio G, Sacchi A.

FASEB J. 2009 Nov;23(11):3957-66. doi: 10.1096/fj.09-131847. Epub 2009 Jul 16.

PMID:
19608627
13.

Growth inhibition by microRNAs that target the insulin receptor substrate-1.

La Rocca G, Shi B, Badin M, De Angelis T, Sepp-Lorenzino L, Baserga R.

Cell Cycle. 2009 Jul 15;8(14):2255-9. Epub 2009 Jul 14.

PMID:
19502786
14.

Mechanism of growth inhibition by MicroRNA 145: the role of the IGF-I receptor signaling pathway.

La Rocca G, Badin M, Shi B, Xu SQ, Deangelis T, Sepp-Lorenzinoi L, Baserga R.

J Cell Physiol. 2009 Aug;220(2):485-91. doi: 10.1002/jcp.21796.

PMID:
19391107
15.

AMG 479, a fully human anti-insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells.

Beltran PJ, Mitchell P, Chung YA, Cajulis E, Lu J, Belmontes B, Ho J, Tsai MM, Zhu M, Vonderfecht S, Baserga R, Kendall R, Radinsky R, Calzone FJ.

Mol Cancer Ther. 2009 May;8(5):1095-105. doi: 10.1158/1535-7163.MCT-08-1171. Epub 2009 Apr 14.

16.

Customizing the targeting of IGF-1 receptor.

Baserga R.

Future Oncol. 2009 Feb;5(1):43-50. doi: 10.2217/14796694.5.1.43. Review.

PMID:
19243297
17.

The insulin receptor substrate-1: a biomarker for cancer?

Baserga R.

Exp Cell Res. 2009 Mar 10;315(5):727-32. doi: 10.1016/j.yexcr.2008.09.017. Epub 2008 Oct 1. Review.

PMID:
18851963
18.

The role of insulin receptor substrate-1 in the oncogenicity of simian virus 40 T antigen.

Wu A, Chen J, Baserga R.

Cell Cycle. 2008 Jul 1;7(13):1999-2002.

PMID:
18642444
19.

Regulation of insulin receptor substrate-1 expression levels by caveolin-1.

Chen J, Capozza F, Wu A, Deangelis T, Sun H, Lisanti M, Baserga R.

J Cell Physiol. 2008 Oct;217(1):281-9. doi: 10.1002/jcp.21498.

PMID:
18506777
20.

The role of insulin receptor substrate-1 in transformation by v-src.

Sun H, Baserga R.

J Cell Physiol. 2008 Jun;215(3):725-32.

PMID:
18064649
21.

What's in a name?

Baserga R.

Science. 2007 Nov 16;318(5853):1066. No abstract available.

PMID:
18006723
22.

Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells.

Shi B, Sepp-Lorenzino L, Prisco M, Linsley P, deAngelis T, Baserga R.

J Biol Chem. 2007 Nov 9;282(45):32582-90. Epub 2007 Sep 7.

23.

Nuclear insulin receptor substrate-1 activates promoters of cell cycle progression genes.

Wu A, Chen J, Baserga R.

Oncogene. 2008 Jan 10;27(3):397-403. Epub 2007 Aug 13.

PMID:
17700539
24.

Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling.

Sun H, Tu X, Liu M, Baserga R.

J Cell Physiol. 2007 Sep;212(3):780-6.

PMID:
17443674
25.

Is cell size important?

Baserga R.

Cell Cycle. 2007 Apr 1;6(7):814-6. Epub 2007 Apr 22. Review.

PMID:
17404503
26.

Insulin receptor substrate-1 regulates the transformed phenotype of BT-20 human mammary cancer cells.

Dalmizrak O, Wu A, Chen J, Sun H, Utama FE, Zambelli D, Tran TH, Rui H, Baserga R.

Cancer Res. 2007 Mar 1;67(5):2124-30.

27.
28.

Downregulation of the upstream binding factor1 by glycogen synthase kinase3beta in myeloid cells induced to differentiate.

Liu M, Tu X, Ferrari-Amorotti G, Calabretta B, Baserga R.

J Cell Biochem. 2007 Apr 1;100(5):1154-69.

PMID:
17063482
29.

Expression profiles of micro RNA in proliferating and differentiating 32D murine myeloid cells.

Shi B, Prisco M, Calin G, Liu CG, Russo G, Giordano A, Baserga R.

J Cell Physiol. 2006 Jun;207(3):706-10.

PMID:
16482530
30.

Building a cathedral.

Baserga R.

Cancer Biol Ther. 2006 Feb;5(2):240-2. Epub 2006 Feb 17. No abstract available.

PMID:
16479150
31.

Transformation by the simian virus 40 T antigen is regulated by IGF-I receptor and IRS-1 signaling.

DeAngelis T, Chen J, Wu A, Prisco M, Baserga R.

Oncogene. 2006 Jan 5;25(1):32-42.

PMID:
16170362
32.

The insulin-like growth factor-I receptor as a target for cancer therapy.

Baserga R.

Expert Opin Ther Targets. 2005 Aug;9(4):753-68. Review.

PMID:
16083341
33.

Functional significance of type 1 insulin-like growth factor-mediated nuclear translocation of the insulin receptor substrate-1 and beta-catenin.

Chen J, Wu A, Sun H, Drakas R, Garofalo C, Cascio S, Surmacz E, Baserga R.

J Biol Chem. 2005 Aug 19;280(33):29912-20. Epub 2005 Jun 20.

34.

24p3 in differentiation of myeloid cells.

Liu M, Prisco M, Drakas R, Searles D, Baserga R.

J Cell Physiol. 2005 Nov;205(2):302-9.

PMID:
15895393
35.
36.

Regulation of upstream binding factor 1 activity by insulin-like growth factor I receptor signaling.

Wu A, Tu X, Prisco M, Baserga R.

J Biol Chem. 2005 Jan 28;280(4):2863-72. Epub 2004 Nov 8.

37.

Targeting the IGF-1 receptor: from rags to riches.

Baserga R.

Eur J Cancer. 2004 Sep;40(14):2013-5. No abstract available.

PMID:
15341972
39.

Role of pescadillo in the transformation and immortalization of mammalian cells.

Maiorana A, Tu X, Cheng G, Baserga R.

Oncogene. 2004 Sep 16;23(42):7116-24.

PMID:
15273728
40.

Control of cell size through phosphorylation of upstream binding factor 1 by nuclear phosphatidylinositol 3-kinase.

Drakas R, Tu X, Baserga R.

Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9272-6. Epub 2004 Jun 14.

41.

Role of pescadillo and upstream binding factor in the proliferation and differentiation of murine myeloid cells.

Prisco M, Maiorana A, Guerzoni C, Calin G, Calabretta B, Voit R, Grummt I, Baserga R.

Mol Cell Biol. 2004 Jun;24(12):5421-33.

42.

Subcellular localization of IRS-1 in cell proliferation and differentiation.

Tu X, Wu A, Maiorana A, Baserga R.

Horm Metab Res. 2003 Nov-Dec;35(11-12):734-9. Erratum in: Horm Metab Res. 2004 Jan;36(1):72.

PMID:
14710352
43.

The IGF-1 receptor in cancer biology.

Baserga R, Peruzzi F, Reiss K.

Int J Cancer. 2003 Dec 20;107(6):873-7. Review.

44.

Intracellular redistribution of nuclear and nucleolar proteins during differentiation of 32D murine hemopoietic cells.

Tu X, Baffa R, Luke S, Prisco M, Baserga R.

Exp Cell Res. 2003 Aug 1;288(1):119-30.

PMID:
12878164
45.

Signaling differences from the A and B isoforms of the insulin receptor (IR) in 32D cells in the presence or absence of IR substrate-1.

Sciacca L, Prisco M, Wu A, Belfiore A, Vigneri R, Baserga R.

Endocrinology. 2003 Jun;144(6):2650-8.

PMID:
12746329
46.

Nuclear translocation of insulin receptor substrate-1 by the insulin receptor in mouse embryo fibroblasts.

Wu A, Sciacca L, Baserga R.

J Cell Physiol. 2003 Jun;195(3):453-60.

PMID:
12704655
47.

Insulin-like growth factor I receptor signaling and nuclear translocation of insulin receptor substrates 1 and 2.

Sun H, Tu X, Prisco M, Wu A, Casiburi I, Baserga R.

Mol Endocrinol. 2003 Mar;17(3):472-86. Epub 2002 Dec 6.

PMID:
12554758
48.

Nuclear translocation of insulin receptor substrate-1 by oncogenes and Igf-I. Effect on ribosomal RNA synthesis.

Tu X, Batta P, Innocent N, Prisco M, Casaburi I, Belletti B, Baserga R.

J Biol Chem. 2002 Nov 15;277(46):44357-65. Epub 2002 Aug 28.

49.

IGF1 receptor expression protects against microenvironmental stress found in the solid tumor.

Peretz S, Kim C, Rockwell S, Baserga R, Glazer PM.

Radiat Res. 2002 Aug;158(2):174-80.

PMID:
12105987
50.

Nuclear translocation of insulin receptor substrate-1 by the simian virus 40 T antigen and the activated type 1 insulin-like growth factor receptor.

Prisco M, Santini F, Baffa R, Liu M, Drakas R, Wu A, Baserga R.

J Biol Chem. 2002 Aug 30;277(35):32078-85. Epub 2002 Jun 12.

Supplemental Content

Loading ...
Support Center